Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
OCuSOFT Lid Scrub Plus Extra Strength
- Development stage
- Unknown
- Lead developer
- OCuSOFT
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
OCuSOFT Lid Scrub Plus Extra Strength is an over-the-counter, leave-on topical eyelid cleanser developed by OCuSOFT, Inc. It is specifically formulated for the management of moderate to severe eyelid conditions, including blepharitis and meibomian gland dysfunction (MGD). The product features a patented blend of surfactants and a preservative system that provides antibacterial activity against microorganisms commonly found on the eyelids. Key functional ingredients include polyaminopropyl biguanide, an antiseptic agent, and 1,2-octanediol, which contributes to the antimicrobial profile. Unlike standard eyelid cleansers that require rinsing, this 'Plus' formulation is designed to be left on the skin to effectively remove oil, debris, and contaminants while providing prolonged antibacterial effects and moisturizing the eyelid area.
- Brand names
- OCuSOFT Lid Scrub Plus Extra StrengthOCuSOFT Lid Scrub Plus
- Other names
- OCuSOFT Plus foamOCuSOFT Lid Scrub PLUS Pre-Moistened Pads
Beyond the preview
Go deeper on OCuSOFT Lid Scrub Plus Extra Strength.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OCuSOFT Lid Scrub Plus Extra Strength.